TrialClinical and experimental nephrology2023

Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.

Shoichi Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.